Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19
Cristina Borralleras, Javier Castrodeza, Pilar Arrazola, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 5, pp. 507-515
Open Access | Times Cited: 10

Showing 10 citing articles:

Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Vaccine (2025) Vol. 47, pp. 126685-126685
Open Access
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial
María Jesús López Fernandez, Silvia Narejos, Antoni Castro-Guardiola, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Innovations and Challenges in the Development of COVID-19 Vaccines for a Safer Tomorrow
Devika Sanil Kumar, Krishna Prasanth Baalann, A Bhandari, et al.
Cureus (2024)
Open Access | Times Cited: 1
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
Patricia Pérez, Guillermo Albericio, David Astorgano, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Myocarditis Associated with COVID-19 Vaccination
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 1
Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months
María Jesús López, M.M. Vazquez, M. Álvarez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
María Jesús López Fernández, Silvia Narejos, Antoni Castro-Guardiola, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 840-840
Open Access
Autumn 2023 SARS-CoV-2 immunization: Who should be vaccinated and how?
F.A. Moraga Llop, Magda Campins
Vacunas (English Edition) (2023) Vol. 24, Iss. 4, pp. 261-265
Closed Access | Times Cited: 1
Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar?
F.A. Moraga Llop, Magda Campins
Vacunas (2023) Vol. 24, Iss. 4, pp. 261-265
Closed Access
Page 1

Scroll to top